Nuvectis Pharma, Inc. - NVCT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 05, 2026 | Vice President, Finance | A | A | 30,000.0 | 0.0 | 0.0 | 230,118.0 | View | |
| Jul 01, 2026 | — | P | A | 50,000.0 | 18.32 | 916,000.0 | 3,186,576.0 | View | |
| Jul 01, 2026 | Chairman & CEO | P | A | 12,500.0 | 20.0 | 250,000.0 | 3,688,424.0 | View | |
| Jun 12, 2026 | — | A | A | 35,000.0 | 0.0 | 0.0 | 168,140.0 | View | |
| Jun 12, 2026 | — | A | A | 35,000.0 | 0.0 | 0.0 | 122,828.0 | View | |
| Jun 12, 2026 | — | A | A | 35,000.0 | 0.0 | 0.0 | 113,380.0 | View | |
| Jun 12, 2026 | — | A | A | 35,000.0 | 0.0 | 0.0 | 159,760.0 | View |